Updated · 1 episodes · 1 show · 1 source notes

entity

ByHealth / 汤臣倍健

Overview

ByHealth / 汤臣倍健 is the Chinese supplement company the source uses as the domestic comparison point for marketing intensity, arguing that heavy selling expense is the category’s real competitive axis.

Current Profile

The episode cites the company’s 2026 half-year report as showing a selling-expense ratio of 42%, at a time when revenue and profit growth are said to lag the growth of that spending. The figure is used to support the source’s argument that the supplement industry has little hard technical or regulatory differentiation, so companies compete mainly through distribution and advertising, and that this competition is becoming less efficient for everyone.

Key Characteristics

  • Domestic Chinese supplement comparator to the Australian brand story.
  • Marketing-led cost structure, with selling expenses reported above 40% of revenue.
  • Spending growth described as outrunning revenue and profit growth.
  • Used as evidence that category competition is marketing-driven rather than evidence-driven.
  • Source-scoped accounting: the page records one episode’s reading of a company filing.

Evidence

Qualifications

The page rests on a single podcast sentence about a filing, without segment detail, channel mix, or trend history. Readers should treat the ratio as a reported figure requiring verification against the company’s own disclosures before being used for comparison.

What Changed

  • Created the page as the Chinese marketing-intensity comparator in the supplement branch.

Relationships

Sources

1 source notes across 1 show
  1. Vol.275 澳洲保健品是怎么火起来的? 商业就是这样